Skip to Main content Skip to Navigation
Journal articles

Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors.

Abstract : Modafinil is a well-tolerated medication for excessive sleepiness, attention-deficit disorder, cocaine dependence and as an adjunct to antidepressants with low propensity for abuse. We investigated the modafinil action on identified dopaminergic and GABAergic neurons in the ventral tegmental area (VTA) and substantia nigra (SN) of rat brain slices. Modafinil (20 microM) inhibited the firing of dopaminergic, but not GABAergic neurons. This inhibition was maintained in the presence of tetrodotoxin and was accompanied by hyperpolarization. Sulpiride (10 microM), a D2-receptor antagonist, but not prazosine (20 microM, an alpha1-adrenoreceptor blocker) abolished the modafinil action. Inhibition of dopamine reuptake with a low dose of nomifensine (1 microM) reduced the firing of DA neurons in a sulpiride-dependent manner and blunted the effect of modafinil. On acutely isolated neurons, modafinil evoked D2-receptor-mediated outward currents in tyrosine-hydroxylase positive cells, identified by single-cell RT-PCR, which reversed polarity near the K(+) equilibrium potential and were unchanged in the presence of nomifensine. Thus modafinil directly inhibits DA neurons through D2 receptors.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00408025
Contributor : Jean-Pierre Sastre <>
Submitted on : Tuesday, July 28, 2009 - 2:10:02 PM
Last modification on : Thursday, November 21, 2019 - 2:23:48 AM
Long-term archiving on: : Saturday, November 26, 2016 - 11:39:37 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Tatiana Korotkova, Boris Klyuch, Alexei Ponomarenko, Jian-Sheng Lin, Helmut Haas, et al.. Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors.. Neuropharmacology, Elsevier, 2007, 52 (2), pp.626-33. ⟨10.1016/j.neuropharm.2006.09.005⟩. ⟨inserm-00408025⟩

Share

Metrics

Record views

543